Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Prolonged-release Potassium Chloride Generics bulk supplier for pharma manufacturers

Prolonged-Release Potassium Chloride Generics Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg)

Reference Brands: Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU)

Category: Nephrology

Prolonged-release Potassium Chloride is an oral electrolyte supplement used to treat and prevent hypokalemia, especially in CKD and patients on diuretics, offering controlled potassium release for stable serum levels.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Prolonged-release Potassium Chloride is a vital electrolyte supplement used to treat and prevent hypokalemia in patients with chronic kidney disease (CKD), heart conditions, or those on diuretic therapy. Designed for steady potassium release, it helps maintain optimal serum potassium levels, reducing the risk of cardiac arrhythmias and muscle dysfunction. Widely prescribed in both the US and EU, it plays a crucial role in nephrology and cardiology. Ideal for B2B pharmaceutical supply, it is available in various strengths to meet diverse patient needs. Prolonged-release Potassium Chloride supports safe, effective potassium repletion in renal and electrolyte management protocols.

Prolonged-Release Potassium Chloride Generics — third party manufacturing & bulk supply

Prolonged-Release Potassium Chloride Generics is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Prolonged-Release Potassium Chloride Generics is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Prolonged-Release Potassium Chloride Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Prolonged-Release Potassium Chloride Gen... →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Prolonged-release Potassium Chloride Generics is listed as Tablet in 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Prolonged-release Potassium Chloride Generics is referenced against Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Prolonged-release Potassium Chloride Generics is catalogued under Nephrology on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Atrasentan Hydrochloride

Strength:
0.75 mg, 1.25 mg, 10 mg

Form: Tablets

Reference Brands: Xinlay (USA/EU), Vanrafia (USA/LATAM)

View Details
Tiopronin

Strength:
100 mg, 200 mg , 300 mg

Form: Tablets, Capsules

Reference Brands: Thiola (USA), Mercaptamine (EU)

View Details
Nedosiran

Strength:
80 mg, 160 mg

Form: Injection

Reference Brands: Ryplazim (USA)

View Details
Probenecid

Strength:
500 mg

Form: Tablets

Reference Brands: Benemid (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.